Geminin overexpression-dependent recruitment and crosstalk with mesenchymal stem cells enhance aggressiveness in triple negative breast cancers
Suryatheja Ananthula(University of Mississippi Medical Center), Wael M. ElShamy(University of Mississippi Medical Center)
Cited by 22
Related Papers
BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers
|Breast Cancer Research|2015|49
Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation, leading to aneuploidy in human mammary epithelial cells
|Breast Cancer Research|2011|32
<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" id="M1"><mml:mrow><mml:mi mathvariant="bold-italic">δ</mml:mi></mml:mrow></mml:math>-Tocotrienol Oxazine Derivative Antagonizes Mammary Tumor Cell Compensatory Response to CoCl<sub><b>2</b></sub>-Induced Hypoxia
|BioMed Research International|2014|13